Endo International PLC (ENDP)

ENDP (NASDAQ:Drugs) EQUITY
$80.82
pos +1.20
+1.50%
Today's Range: 80.13 - 81.64 | ENDP Avg Daily Volume: 2,341,400
Last Update: 07/01/15 - 3:59 PM EDT
Volume: 1,416,195
YTD Performance: 10.44%
Open: $80.22
Previous Close: $79.65
52 Week Range: $57.14 - $96.58
Oustanding Shares: 178,746,233
Market Cap: 14,011,917,205
6-Month Chart
TheStreet Ratings Grade for ENDP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 8 8 8
Moderate Buy 2 2 2 2
Hold 5 4 4 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.88 1.68 1.68 1.77
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -21.19
Price Earnings Comparisons:
ENDP Sector Avg. S&P 500
-21.19 0.00 26.07
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-12.98% 13.75% 157.10%
GROWTH 12 Mo 3 Yr CAGR
Revenue 9.90 0.05 0.02
Net Income 0.00 -3.99 0.00
EPS 0.00 -4.05 0.00
Earnings for ENDP:
EBITDA 0.89B
Revenue 2.88B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.02 $1.11 $4.51 $5.36
Number of Analysts 7 7 9 8
High Estimate $1.09 $1.19 $4.57 $5.90
Low Estimate $0.98 $0.93 $4.46 $4.89
Prior Year $1.06 $1.15 $4.31 $4.51
Growth Rate (Year over Year) -3.37% -3.35% 4.74% 18.76%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | May 18, 2015 | 3:24 PM EDT

Acquisitions cut into overabundance of companies.

By

Timothy Collins

 | May 13, 2015 | 12:30 PM EDT

Endo Pharmaceuticals could offer a short-term play.

bullishEndo estimates, target boosted at Deutsche

Apr 13, 2015 | 8:15 AM EDT

Shares of ENDP now seen reaching $96, according to Deutsche Bank. Estimates also upped, as Xiaflex should drive growth. Buy rating. 

By

Jim Cramer

 | Mar 16, 2015 | 9:30 AM EDT

Take a look at some more of its recent moves.

By

Timothy Collins

 | Mar 10, 2015 | 4:12 PM EDT

It's wise to stick with strength right now.

By

David Katz

 | Nov 25, 2014 | 2:30 PM EST

Whether it's acquiring or the acquired, Mylan is building shareholder value.

bullishEndo Health Solutions upgraded at Cantor Fitzgerald

Oct 13, 2014 | 7:54 AM EDT

ENDP upgraded to Hold, said Cantor Fitzgerald. Auxilium deal should be accretive to EPS with longer term increases in EBITDA, possibly facilitating additional M&A. 

bullishEndo upgraded at Morgan Stanley

May 2, 2014 | 8:10 AM EDT

ENDP was upgraded from Equal-weight to Overweight, Morgan Stanley said. $79 price target. Mesh settlement removes a multi-billion dollar liability. 

bullishEndo Health Solutions price target raised at UBS

Mar 3, 2014 | 7:47 AM EST

ENDP bumped up its number, UBS said. Driven by continud performance of base business and potential for accretive deals. $90 price target and Buy rating. 

By

Herb Greenberg

 | Jan 15, 2014 | 9:00 AM EST

This rollup name is on the stock-market equivalent of steroids.

I'm not sure Twitter will find its legs until they get a new CEO but I think Periscope alo...
The energy sector(OIH -3.5%)is limping into the close. The big equipment names like S...

AAPL iMessage, Mail, Backup Photos and other services all down...

Bob, I saw that crowdfunding story on Greece yesterday. It reminded me of studies that sh...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.